Filing Flows › Regenxbio (RGNX) › License and Service revenue
Regenxbio (RGNX) License and Service revenue by quarter
Regenxbio's License and Service revenue was $5.2M in Q3 2026 (third quarter 2026), -95% from Q2 2026. Over the last 3 quarters it ranged from $5.2M (Q3 2026) to $104M (Q2 2026).
| Quarter | License and Service revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.2M | -95% | — |
| Q2 2026 | $104M | +19% | — |
| Q1 2025 | $87.0M | — | — |
Q3 2026 at a glance
Regenxbio, Q3 2026: revenue $9.2M (-69% year over year), operating margin -387.8%, net loss $40.7M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Regenxbio's License and Service revenue?
Regenxbio's License and Service revenue was $5.2M in Q3 2026 (third quarter 2026), -95% from Q2 2026.
How has Regenxbio's License and Service revenue changed?
Over the last 3 quarters it ranged from $5.2M (Q3 2026) to $104M (Q2 2026).